Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) LT-Debt-to-Total-Asset : 2.78 (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Cannabis Bioscience International Holdings's long-term debt to total assests ratio for the quarter that ended in Nov. 2023 was 2.78.

Cannabis Bioscience International Holdings's long-term debt to total assets ratio increased from Nov. 2011 (0.01) to Nov. 2023 (2.78). It may suggest that Cannabis Bioscience International Holdings is progressively becoming more dependent on debt to grow their business.

Cannabis Bioscience International Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Cannabis Bioscience International Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings LT-Debt-to-Total-Asset Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

LT-Debt-to-Total-Asset

0.48

0.03

0.01

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial							0.02	0.01	0.01	-	2.78

Cannabis Bioscience International Holdings LT-Debt-to-Total-Asset Calculation

Cannabis Bioscience International Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in May. 2011 is calculated as

LT Debt to Total Assets (A: May. 2011 )	=	Long-Term Debt & Capital Lease Obligation (A: May. 2011 )	/	Total Assets (A: May. 2011 )
	=	0.516	/	93.043
	=	0.01

Cannabis Bioscience International Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

LT Debt to Total Assets (Q: Nov. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Nov. 2023 )	/	Total Assets (Q: Nov. 2023 )
	=	0.283	/	0.102
	=	2.77

Cannabis Bioscience International Holdings (OTCPK:CBIH) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Cannabis Bioscience International Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.